Показать сокращенную информацию
dc.contributor.author | Litvin Y. | |
dc.contributor.author | Zakirova E. | |
dc.contributor.author | Zhuravleva M. | |
dc.contributor.author | Rizvanov A. | |
dc.date.accessioned | 2018-09-19T23:12:04Z | |
dc.date.available | 2018-09-19T23:12:04Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 2191-1630 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/146053 | |
dc.description.abstract | © 2016, Springer Science+Business Media New York.In this study, we have generated a dual expression cassette plasmid DNA (pDNA) construct containing the species-specific horse (Equus caballus) codon optimized sequence encoding potent pro-angiogenic vascular endothelial growth factor (VEGF164) and basic fibroblast growth factor (FGF2) under eukaryotic promoters (EF-1α and CMV promoters, respectively). We have demonstrated effective and simultaneous recombinant proteins expression in vitro. Resulting pDNA is suitable for potential gene therapy applications in horses. | |
dc.relation.ispartofseries | BioNanoScience | |
dc.subject | Fibroblast growth factor 2 | |
dc.subject | Gene therapy | |
dc.subject | Horse | |
dc.subject | Plasmid DNA | |
dc.subject | Vascular endothelial growth factor 164 | |
dc.title | Generation of Plasmid DNA Expressing Species-Specific Horse VEGF164 and FGF2 Factors for Gene Therapy | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 4 | |
dc.relation.ispartofseries-volume | 6 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 550 | |
dc.source.id | SCOPUS21911630-2016-6-4-SID84999836876 |